BMP-2 tethered hydroxyapatite for bone tissue regeneration: Coating chemistry and osteoblast attachment

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 11, 2012, Pages 3117-3123

  Shiels, Stefanie M ^a,b   Solomon, Kimberly D ^a,b   Pilia, Marcello ^a,b   Appleford, Mark R ^a,b   Ong, Joo L ^a,b  

^a The University of Texas at San Antonio   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

BMP 2; Cell attachment; Controlled release; Hydroxyapatite; Polyelectrolyte

Indexed keywords

ADSORPTION; COATINGS; HYDROXYAPATITE; POLYELECTROLYTES; POLYETHYLENE GLYCOLS; TETHERLINES; TISSUE;

ADSORPTION METHOD; BMP-2; BONE TISSUE REGENERATION; BURST RELEASE; CELL ATTACHMENTS; CELLULAR ATTACHMENTS; CELLULAR INTERACTION; CONTROLLED RELEASE; OSTEOBLAST CELLS; POLYETHYLENEIMINE; RECOMBINANT BONE MORPHOGENETIC PROTEIN-2; RELEASE PROPERTY; RHBMP-2;

SURFACES;

HYDROXYAPATITE; MACROGOL; POLYETHYLENEIMINE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADSORPTION; ARTICLE; BONE REGENERATION; CELL STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOBLAST;

EID: 84869085018     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34241     Document Type: Article

References (35)

1. Bessa P, Casal M, Reis R. Bone morphogenetic proteins in tissue engineering: The road from laboratory to clinic, part II (BMP Delivery). J Tissue Eng Regen Med 2008;2:81-96.
2. Bauer T, Muschler G. Bone graft mateials. An overview of the basic science. Clin Orthop Relat Res 2000;371:10-27. (Pubitemid 30090817)
3. Si X, Yang L, Jin Y. Induction of osteogenic potential of fibroblasts by transfection of rhBMP-2. In: Lindholm T, editor. Advances in Skeletal Reconstruction Using Bone Morphogenetic Proteins. Singapore: World Scientific Publishing; 2002. p 19-34.
4. Lee S, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 2007;59:339-359. (Pubitemid 46879973)
5. Sasso R, LeHuec J, Shaffrey C. Ilicac crest bone graft donor site pain after anterior lumbar interbody fusion: A prospective patient satisfaction outcome assessment. J Spinal Disord Tech 2005;18:S77-S81. (Pubitemid 44620804)
6. Zimmermann G, Moghaddam A. Allograft bone matrix versus synthetic bone graft substitute. Injury, Int J Care Injured 2011;42:S16-S21.
7. Bessa P, Casal M, Reis R. Bone morphogenetic proteins in tissue engineering: The road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008;2:1-13.
8. Wang EA, Rosen V, Dalessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, Lapan P, Luxemberg DP, McQuaid D, Moutsatsos IK, Nove J, Wozney JM. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87:2220-2224.
9. Wozney J, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 1998;346:26-37. (Pubitemid 28046864)
10. Murakami N, Saita N, Takahashi J, Ota H, Horiuchi H, Nawata M, Okada T, Nozaki K, Takaoka K. Repair of a proximal femoral bone defect in dogs using a porous surface prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 2003;24:2153-2159. (Pubitemid 36434033)
11. Seeherman H, Bouxsein M, Kim H, Li R, Li X, Aiolova M, Wozney J. Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomysite healing in a nonhuman primate model. J Bone Joint Surg Am 2004;86 A: 1961-1972. (Pubitemid 39232119)
12. Kon T, Yamazaki M, Tagawa M, Goto S, Terakado A, Moriya H, Fujimura S. Bone morphogenetic protein-2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudnal ligament. Calcif Tissue Int 1997;60:291-296. (Pubitemid 27106255)
13. Zara JN, Siu RK, Zhang XL, Shen J, Ngo R, Lee M, Li WM, Chiang M, Chung J, Kwak J, Wu BM, Ting K, Soo C. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng A 2011;17(9, 10):1389-1399.
14. Shields L, Raque G, Glassman S, Campbell M, Vitaz T, Harpring J, Shields C. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. SPINE 2006;31:542-547.
15. Dai K, Xu X, Tang T, Zhu Z, Yu C, Lou J, Zhang X. Repairing of goat tibial defects with BMP-2 gene-modified tissue engineered bone. Calc Tissue Int 2005;77:55-61. (Pubitemid 41504173)
16. Karageorgiou V, Meinel L, Hofmann S, Malhotra A, Volloch V, Kaplan D. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 2004;71:528-537. (Pubitemid 39489907)
17. Zhang S, Wright J, Ozber N, Uludag H. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite. Macromol Biosci 2007;7:656-670. (Pubitemid 47264639)
18. Kuhl P, Griffith-Cima L. Tethered epidermal growth factor as a paradigm for growth-factor induced stimulation from the solid phase. Nat Med 1996;2:1022-1027. (Pubitemid 26306842)
19. Zhang S, Wnag G, Lin X. Polyethylenimine-coated albumin nanoparticles for BMP-2 delivery. Biotechnol Prog 2008;24:945-956.
20. Kang H, Bae Y. A reducible polycationic gene vector derived from thiolated low molecular weight branched polyethyleneimine linked by 2-iminothiolane. Biomaterials 2011;32:1193-1203.
21. Bullock J, Chowdhury S, Severdia A, Sweeney J, Johnston D, Pachla L. Comparison of results of various methods used to determine the extent of modification of methoxy polyethylene glycol 5000-modified bovine cupri-zinc superoxide dismutase. Anal Biochem 1997;254:254-262. (Pubitemid 28021089)
22. Kiely J, Bonnell D. Quantification of topographic structure by scanning probe microscopy. J Vac Sci Technol B 1997;15:1483-1493. (Pubitemid 127629143)
23. Luginbuehl V, Meinel L, Merkle H, Gander B. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004;58:197-208. (Pubitemid 39037229)
24. Folkman J, Long D. The use of silicone rubber as a carrier for prolonged drug therapy. J Surg Res 1964;4:139-142.
25. Wissink M, Beernink R, Poot A, Engbers G, Beugeling T, van Aken W, Feijen J. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Controlled Release 2000;64:103-114. (Pubitemid 30035311)
26. Wallace D, Rosenblatt J. Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Deliv Rev 2003;55:1631-1649. (Pubitemid 37412596)
27. Zhang Y, Cheng X, Wand J, Wang Y, Shi B, Huang C, Yang X, Liu T. Novel chitosan/collagen scaffold containing transforming growth factor b1 DNA for periodontal tissue engineering. Biochem Biophys Res Commun 2006;344:362-369.
28. Traut RR, Bollen A, Sun TT, Hershey JWB, Sundberg J, Pierce LR. Methyl-4-mercaptobutyrimidate as a cleavable crosslinking reagent and its application to escherichia-coli 30S ribosome. Biochemistry 1973;12:3266-3273.
29. Oliveira A, Gemming S, Seifert G. Conformational analysis of aqueous BMP-2 using atomisticmolecular dynamics simulations. J Phys Chem B 2011;115:1122-1130.
30. Schuessele A, Mayr H, Tessmar J, Goepferich. Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. J Biomed Mater Res A 2009;90:959-971.
31. Liu H, Chen C, Tsai C, Lin I, Hsiue G. Heterbiofunctional poly (ethylene glycol)-tethered bone morphogenetic protein-2-stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis. Tissue Eng. 2007;13:1113-1124. (Pubitemid 46870435)
32. Seeherman H, Wozney J. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005;16:329-345. (Pubitemid 40910322)
33. Pietrzak W, Woodell-May J, McDonald N. Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix. J Craniofac Surg 2006;17:84-90. (Pubitemid 44383852)
34. Blum B, Moseley J, Miller L, Richelsoph K, Haggard W. Measurement of bone morphogenetic proteins and other growth factors in dimineralized bone matrix. Orthopaedics 2004;27:S161-S165. (Pubitemid 38159820)
35. Kanim LEA, Bae H, Zhao L, Delamarter R, Dawson EG. Inter and intravariability of BMPs in commercially available demineralized bone matrices. Spine J 2003;3:81S.